nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—SLC19A1—Metabolism of folate and pterines—MTHFR—glaucoma	0.032	0.0946	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism of folate and pterines—MTHFR—glaucoma	0.0272	0.0805	CbGpPWpGaD
Pralatrexate—SLC19A1—Treprostinil—Latanoprost—glaucoma	0.0158	0.646	CbGdCrCtD
Pralatrexate—DHFR—Metabolism of folate and pterines—MTHFR—glaucoma	0.0113	0.0336	CbGpPWpGaD
Pralatrexate—Pharyngolaryngeal pain—Brinzolamide—glaucoma	0.0099	0.0159	CcSEcCtD
Pralatrexate—Laryngeal pain—Brinzolamide—glaucoma	0.00981	0.0158	CcSEcCtD
Pralatrexate—FPGS—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00961	0.0285	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—ABCA1—glaucoma	0.00919	0.0272	CbGpPWpGaD
Pralatrexate—FPGS—Treprostinil—Latanoprost—glaucoma	0.00865	0.354	CbGdCrCtD
Pralatrexate—SLC19A1—Folate Metabolism—SOD1—glaucoma	0.00819	0.0242	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—ATOH7—glaucoma	0.00793	0.0235	CbGpPWpGaD
Pralatrexate—Tachycardia—Dipivefrin—glaucoma	0.00792	0.0127	CcSEcCtD
Pralatrexate—Hypokalaemia—Diclofenamide—glaucoma	0.00769	0.0124	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methazolamide—glaucoma	0.00701	0.0113	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Latanoprost—glaucoma	0.00678	0.0109	CcSEcCtD
Pralatrexate—Epistaxis—Metipranolol—glaucoma	0.00674	0.0108	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—MTHFR—glaucoma	0.00649	0.0192	CbGpPWpGaD
Pralatrexate—Pancytopenia—Methazolamide—glaucoma	0.00639	0.0103	CcSEcCtD
Pralatrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—glaucoma	0.00629	0.0186	CbGpPWpGaD
Pralatrexate—Vomiting—Physostigmine—glaucoma	0.00607	0.00975	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Latanoprost—glaucoma	0.00605	0.00972	CcSEcCtD
Pralatrexate—Folic Acid—MTHFR—glaucoma	0.00589	0.373	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—glaucoma	0.00589	0.373	CrCbGaD
Pralatrexate—DHFR—Metabolism of nitric oxide—CAV1—glaucoma	0.00576	0.0171	CbGpPWpGaD
Pralatrexate—Nausea—Physostigmine—glaucoma	0.00567	0.00911	CcSEcCtD
Pralatrexate—Pharyngolaryngeal pain—Timolol—glaucoma	0.00541	0.00869	CcSEcCtD
Pralatrexate—Liver function test abnormal—Bimatoprost—glaucoma	0.00539	0.00866	CcSEcCtD
Pralatrexate—Laryngeal pain—Timolol—glaucoma	0.00535	0.00861	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00532	0.0158	CbGpPWpGaD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.0052	0.0154	CbGpPWpGaD
Pralatrexate—Pain in extremity—Dorzolamide—glaucoma	0.00494	0.00794	CcSEcCtD
Pralatrexate—Hypokalaemia—Acetazolamide—glaucoma	0.0049	0.00788	CcSEcCtD
Pralatrexate—Cough—Metipranolol—glaucoma	0.00488	0.00784	CcSEcCtD
Pralatrexate—Pain in extremity—Brinzolamide—glaucoma	0.00485	0.0078	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Acetazolamide—glaucoma	0.00485	0.0078	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Bimatoprost—glaucoma	0.00469	0.00754	CcSEcCtD
Pralatrexate—DHFR—One Carbon Metabolism—MTHFR—glaucoma	0.00458	0.0136	CbGpPWpGaD
Pralatrexate—Oedema—Metipranolol—glaucoma	0.00456	0.00733	CcSEcCtD
Pralatrexate—Leukopenia—Diclofenamide—glaucoma	0.00456	0.00732	CcSEcCtD
Pralatrexate—Liver function test abnormal—Brinzolamide—glaucoma	0.00448	0.0072	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Dorzolamide—glaucoma	0.00445	0.00715	CcSEcCtD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.00442	0.0131	CbGpPWpGaD
Pralatrexate—Back pain—Latanoprost—glaucoma	0.00439	0.00705	CcSEcCtD
Pralatrexate—DHFR—Metabolism of nitric oxide—NOS3—glaucoma	0.00435	0.0129	CbGpPWpGaD
Pralatrexate—Liver function test abnormal—Pilocarpine—glaucoma	0.00431	0.00692	CcSEcCtD
Pralatrexate—Oedema—Carteolol—glaucoma	0.00422	0.00679	CcSEcCtD
Pralatrexate—Leukopenia—Methazolamide—glaucoma	0.00419	0.00674	CcSEcCtD
Pralatrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00411	0.0122	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Diclofenamide—glaucoma	0.00407	0.00654	CcSEcCtD
Pralatrexate—Dyspnoea—Metipranolol—glaucoma	0.00407	0.00653	CcSEcCtD
Pralatrexate—TYMS—Nucleotide metabolism—TXN—glaucoma	0.00403	0.0119	CbGpPWpGaD
Pralatrexate—Methotrexate—MTHFR—glaucoma	0.00403	0.255	CrCbGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00401	0.0119	CbGpPWpGaD
Pralatrexate—TYMS—One Carbon Metabolism—MTHFR—glaucoma	0.00399	0.0118	CbGpPWpGaD
Pralatrexate—Upper respiratory tract infection—Dorzolamide—glaucoma	0.00397	0.00637	CcSEcCtD
Pralatrexate—Anorexia—Diclofenamide—glaucoma	0.00396	0.00636	CcSEcCtD
Pralatrexate—Dyspnoea—Carteolol—glaucoma	0.00377	0.00605	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—NARFL—glaucoma	0.00376	0.0111	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CA5A—glaucoma	0.00376	0.0111	CbGpPWpGaD
Pralatrexate—Pain in extremity—Clonidine—glaucoma	0.00373	0.00599	CcSEcCtD
Pralatrexate—Oedema—Latanoprost—glaucoma	0.0037	0.00595	CcSEcCtD
Pralatrexate—FPGS—Fluoropyrimidine Activity—TP53—glaucoma	0.00365	0.0108	CbGpPWpGaD
Pralatrexate—Anorexia—Methazolamide—glaucoma	0.00365	0.00586	CcSEcCtD
Pralatrexate—Decreased appetite—Diclofenamide—glaucoma	0.00361	0.0058	CcSEcCtD
Pralatrexate—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00359	0.0106	CbGpPWpGaD
Pralatrexate—Epistaxis—Dorzolamide—glaucoma	0.00359	0.00577	CcSEcCtD
Pralatrexate—Fatigue—Diclofenamide—glaucoma	0.00358	0.00576	CcSEcCtD
Pralatrexate—Dyspnoea—Levobunolol—glaucoma	0.00356	0.00572	CcSEcCtD
Pralatrexate—Constipation—Diclofenamide—glaucoma	0.00355	0.00571	CcSEcCtD
Pralatrexate—Epistaxis—Brinzolamide—glaucoma	0.00353	0.00567	CcSEcCtD
Pralatrexate—TYMS—Fluoropyrimidine Activity—MTHFR—glaucoma	0.0035	0.0104	CbGpPWpGaD
Pralatrexate—Liver function test abnormal—Clonidine—glaucoma	0.00344	0.00553	CcSEcCtD
Pralatrexate—SLC19A1—Disease—LRP12—glaucoma	0.0034	0.0101	CbGpPWpGaD
Pralatrexate—Epistaxis—Pilocarpine—glaucoma	0.00339	0.00545	CcSEcCtD
Pralatrexate—Decreased appetite—Methazolamide—glaucoma	0.00332	0.00534	CcSEcCtD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.00332	0.00983	CbGpPWpGaD
Pralatrexate—Dyspnoea—Latanoprost—glaucoma	0.0033	0.0053	CcSEcCtD
Pralatrexate—Fatigue—Methazolamide—glaucoma	0.0033	0.0053	CcSEcCtD
Pralatrexate—Body temperature increased—Diclofenamide—glaucoma	0.00328	0.00528	CcSEcCtD
Pralatrexate—Asthenia—Metipranolol—glaucoma	0.00327	0.00526	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—ABCA1—glaucoma	0.00326	0.00966	CbGpPWpGaD
Pralatrexate—Body temperature increased—Carbachol—glaucoma	0.0032	0.00515	CcSEcCtD
Pralatrexate—Abdominal pain—Carbachol—glaucoma	0.0032	0.00515	CcSEcCtD
Pralatrexate—FPGS—Metabolism—NARFL—glaucoma	0.00319	0.00946	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CA5A—glaucoma	0.00319	0.00946	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—OPN4—glaucoma	0.00316	0.00935	CbGpPWpGaD
Pralatrexate—Cough—Bimatoprost—glaucoma	0.00307	0.00493	CcSEcCtD
Pralatrexate—Asthenia—Carteolol—glaucoma	0.00303	0.00487	CcSEcCtD
Pralatrexate—Body temperature increased—Methazolamide—glaucoma	0.00302	0.00486	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Clonidine—glaucoma	0.00299	0.00481	CcSEcCtD
Pralatrexate—Asthenia—Diclofenamide—glaucoma	0.00298	0.00479	CcSEcCtD
Pralatrexate—Oedema—Apraclonidine—glaucoma	0.00296	0.00476	CcSEcCtD
Pralatrexate—Hypokalaemia—Betaxolol—glaucoma	0.00295	0.00474	CcSEcCtD
Pralatrexate—Pruritus—Diclofenamide—glaucoma	0.00294	0.00472	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Betaxolol—glaucoma	0.00292	0.00469	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—SOD1—glaucoma	0.00291	0.00861	CbGpPWpGaD
Pralatrexate—Leukopenia—Acetazolamide—glaucoma	0.0029	0.00467	CcSEcCtD
Pralatrexate—FPGS—Disease—LRP12—glaucoma	0.00289	0.00856	CbGpPWpGaD
Pralatrexate—Back pain—Dorzolamide—glaucoma	0.00288	0.00462	CcSEcCtD
Pralatrexate—Rash—Metipranolol—glaucoma	0.00288	0.00462	CcSEcCtD
Pralatrexate—Dermatitis—Metipranolol—glaucoma	0.00287	0.00462	CcSEcCtD
Pralatrexate—Asthenia—Levobunolol—glaucoma	0.00286	0.0046	CcSEcCtD
Pralatrexate—Back pain—Travoprost—glaucoma	0.00286	0.0046	CcSEcCtD
Pralatrexate—Back pain—Brinzolamide—glaucoma	0.00283	0.00454	CcSEcCtD
Pralatrexate—Pruritus—Levobunolol—glaucoma	0.00282	0.00454	CcSEcCtD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.00282	0.00836	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—TNF—glaucoma	0.00279	0.00828	CbGpPWpGaD
Pralatrexate—Diarrhoea—Carbachol—glaucoma	0.00277	0.00446	CcSEcCtD
Pralatrexate—Asthenia—Methazolamide—glaucoma	0.00274	0.00441	CcSEcCtD
Pralatrexate—Diarrhoea—Levobunolol—glaucoma	0.00273	0.00439	CcSEcCtD
Pralatrexate—Back pain—Pilocarpine—glaucoma	0.00272	0.00437	CcSEcCtD
Pralatrexate—Cough—Brimonidine—glaucoma	0.00272	0.00437	CcSEcCtD
Pralatrexate—Nausea—Metipranolol—glaucoma	0.00271	0.00435	CcSEcCtD
Pralatrexate—Epistaxis—Clonidine—glaucoma	0.00271	0.00435	CcSEcCtD
Pralatrexate—Pain in extremity—Timolol—glaucoma	0.00265	0.00426	CcSEcCtD
Pralatrexate—Vomiting—Diclofenamide—glaucoma	0.00264	0.00424	CcSEcCtD
Pralatrexate—Dyspnoea—Apraclonidine—glaucoma	0.00264	0.00424	CcSEcCtD
Pralatrexate—Pruritus—Latanoprost—glaucoma	0.00262	0.00421	CcSEcCtD
Pralatrexate—Rash—Diclofenamide—glaucoma	0.00262	0.00421	CcSEcCtD
Pralatrexate—Diarrhoea—Methazolamide—glaucoma	0.00262	0.00421	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Betaxolol—glaucoma	0.00261	0.00419	CcSEcCtD
Pralatrexate—Cough—Dorzolamide—glaucoma	0.00259	0.00417	CcSEcCtD
Pralatrexate—Thrombocytopenia—Acetazolamide—glaucoma	0.00259	0.00417	CcSEcCtD
Pralatrexate—Cough—Travoprost—glaucoma	0.00258	0.00415	CcSEcCtD
Pralatrexate—Vomiting—Carbachol—glaucoma	0.00258	0.00414	CcSEcCtD
Pralatrexate—Dyspnoea—Bimatoprost—glaucoma	0.00256	0.00411	CcSEcCtD
Pralatrexate—Rash—Carbachol—glaucoma	0.00256	0.00411	CcSEcCtD
Pralatrexate—Dermatitis—Carbachol—glaucoma	0.00255	0.0041	CcSEcCtD
Pralatrexate—Fatigue—Apraclonidine—glaucoma	0.00255	0.0041	CcSEcCtD
Pralatrexate—Cough—Brinzolamide—glaucoma	0.00255	0.0041	CcSEcCtD
Pralatrexate—Oedema—Brimonidine—glaucoma	0.00254	0.00408	CcSEcCtD
Pralatrexate—Constipation—Apraclonidine—glaucoma	0.00253	0.00407	CcSEcCtD
Pralatrexate—Leukopenia—Pilocarpine—glaucoma	0.00251	0.00404	CcSEcCtD
Pralatrexate—Nausea—Carteolol—glaucoma	0.00251	0.00403	CcSEcCtD
Pralatrexate—Tachycardia—Brimonidine—glaucoma	0.00248	0.00399	CcSEcCtD
Pralatrexate—Nausea—Diclofenamide—glaucoma	0.00247	0.00397	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TP53—glaucoma	0.00246	0.0073	CbGpPWpGaD
Pralatrexate—Cough—Pilocarpine—glaucoma	0.00245	0.00394	CcSEcCtD
Pralatrexate—Liver function test abnormal—Timolol—glaucoma	0.00245	0.00393	CcSEcCtD
Pralatrexate—Vomiting—Methazolamide—glaucoma	0.00243	0.00391	CcSEcCtD
Pralatrexate—Oedema—Dorzolamide—glaucoma	0.00243	0.0039	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Apraclonidine—glaucoma	0.00242	0.00389	CcSEcCtD
Pralatrexate—Oedema—Travoprost—glaucoma	0.00242	0.00388	CcSEcCtD
Pralatrexate—Rash—Methazolamide—glaucoma	0.00241	0.00388	CcSEcCtD
Pralatrexate—Dermatitis—Methazolamide—glaucoma	0.00241	0.00387	CcSEcCtD
Pralatrexate—Nausea—Carbachol—glaucoma	0.00241	0.00387	CcSEcCtD
Pralatrexate—Nausea—Levobunolol—glaucoma	0.00237	0.00381	CcSEcCtD
Pralatrexate—Tachycardia—Travoprost—glaucoma	0.00236	0.00379	CcSEcCtD
Pralatrexate—Epistaxis—Betaxolol—glaucoma	0.00236	0.00379	CcSEcCtD
Pralatrexate—Abdominal pain—Apraclonidine—glaucoma	0.00234	0.00376	CcSEcCtD
Pralatrexate—Rash—Latanoprost—glaucoma	0.00233	0.00375	CcSEcCtD
Pralatrexate—Dermatitis—Latanoprost—glaucoma	0.00233	0.00375	CcSEcCtD
Pralatrexate—Tachycardia—Brinzolamide—glaucoma	0.00233	0.00374	CcSEcCtD
Pralatrexate—Anorexia—Dorzolamide—glaucoma	0.00231	0.00372	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—MTHFR—glaucoma	0.00231	0.00683	CbGpPWpGaD
Pralatrexate—Decreased appetite—Acetazolamide—glaucoma	0.0023	0.0037	CcSEcCtD
Pralatrexate—Oedema—Pilocarpine—glaucoma	0.00229	0.00369	CcSEcCtD
Pralatrexate—Fatigue—Acetazolamide—glaucoma	0.00228	0.00367	CcSEcCtD
Pralatrexate—Nausea—Methazolamide—glaucoma	0.00227	0.00365	CcSEcCtD
Pralatrexate—Dyspnoea—Brimonidine—glaucoma	0.00227	0.00364	CcSEcCtD
Pralatrexate—Thrombocytopenia—Pilocarpine—glaucoma	0.00224	0.00361	CcSEcCtD
Pralatrexate—Tachycardia—Pilocarpine—glaucoma	0.00224	0.0036	CcSEcCtD
Pralatrexate—Fatigue—Brimonidine—glaucoma	0.00219	0.00352	CcSEcCtD
Pralatrexate—SLC19A1—Disease—FGFR1OP—glaucoma	0.00219	0.00649	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HEYL—glaucoma	0.00219	0.00649	CbGpPWpGaD
Pralatrexate—Anorexia—Pilocarpine—glaucoma	0.00219	0.00351	CcSEcCtD
Pralatrexate—Dyspnoea—Dorzolamide—glaucoma	0.00216	0.00348	CcSEcCtD
Pralatrexate—Dyspnoea—Travoprost—glaucoma	0.00215	0.00346	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Timolol—glaucoma	0.00213	0.00342	CcSEcCtD
Pralatrexate—Dyspnoea—Brinzolamide—glaucoma	0.00213	0.00342	CcSEcCtD
Pralatrexate—Asthenia—Apraclonidine—glaucoma	0.00212	0.00341	CcSEcCtD
Pralatrexate—Decreased appetite—Dorzolamide—glaucoma	0.00211	0.00339	CcSEcCtD
Pralatrexate—Pruritus—Apraclonidine—glaucoma	0.00209	0.00337	CcSEcCtD
Pralatrexate—Body temperature increased—Acetazolamide—glaucoma	0.00209	0.00336	CcSEcCtD
Pralatrexate—Fatigue—Dorzolamide—glaucoma	0.00209	0.00336	CcSEcCtD
Pralatrexate—Fatigue—Travoprost—glaucoma	0.00208	0.00335	CcSEcCtD
Pralatrexate—Decreased appetite—Brinzolamide—glaucoma	0.00207	0.00333	CcSEcCtD
Pralatrexate—Constipation—Travoprost—glaucoma	0.00207	0.00332	CcSEcCtD
Pralatrexate—Asthenia—Bimatoprost—glaucoma	0.00206	0.00331	CcSEcCtD
Pralatrexate—Fatigue—Brinzolamide—glaucoma	0.00206	0.00331	CcSEcCtD
Pralatrexate—Dyspnoea—Pilocarpine—glaucoma	0.00204	0.00329	CcSEcCtD
Pralatrexate—Pruritus—Bimatoprost—glaucoma	0.00203	0.00326	CcSEcCtD
Pralatrexate—Diarrhoea—Apraclonidine—glaucoma	0.00202	0.00325	CcSEcCtD
Pralatrexate—Decreased appetite—Pilocarpine—glaucoma	0.00199	0.0032	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Dorzolamide—glaucoma	0.00198	0.00319	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Travoprost—glaucoma	0.00198	0.00318	CcSEcCtD
Pralatrexate—Constipation—Pilocarpine—glaucoma	0.00196	0.00315	CcSEcCtD
Pralatrexate—Cough—Clonidine—glaucoma	0.00196	0.00315	CcSEcCtD
Pralatrexate—Epistaxis—Timolol—glaucoma	0.00193	0.0031	CcSEcCtD
Pralatrexate—Abdominal pain—Dorzolamide—glaucoma	0.00192	0.00308	CcSEcCtD
Pralatrexate—Body temperature increased—Dorzolamide—glaucoma	0.00192	0.00308	CcSEcCtD
Pralatrexate—Abdominal pain—Travoprost—glaucoma	0.00191	0.00307	CcSEcCtD
Pralatrexate—Asthenia—Acetazolamide—glaucoma	0.0019	0.00305	CcSEcCtD
Pralatrexate—Vomiting—Apraclonidine—glaucoma	0.00188	0.00302	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Pilocarpine—glaucoma	0.00187	0.00301	CcSEcCtD
Pralatrexate—Dermatitis—Apraclonidine—glaucoma	0.00186	0.003	CcSEcCtD
Pralatrexate—FPGS—Disease—HEYL—glaucoma	0.00186	0.00551	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGFR1OP—glaucoma	0.00186	0.00551	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.00185	0.00547	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CA1—glaucoma	0.00183	0.00543	CbGpPWpGaD
Pralatrexate—Oedema—Clonidine—glaucoma	0.00183	0.00294	CcSEcCtD
Pralatrexate—Asthenia—Brimonidine—glaucoma	0.00182	0.00293	CcSEcCtD
Pralatrexate—Abdominal pain—Pilocarpine—glaucoma	0.00181	0.00291	CcSEcCtD
Pralatrexate—Body temperature increased—Pilocarpine—glaucoma	0.00181	0.00291	CcSEcCtD
Pralatrexate—Diarrhoea—Acetazolamide—glaucoma	0.00181	0.00291	CcSEcCtD
Pralatrexate—Rash—Bimatoprost—glaucoma	0.00181	0.00291	CcSEcCtD
Pralatrexate—Dermatitis—Bimatoprost—glaucoma	0.00181	0.00291	CcSEcCtD
Pralatrexate—Anaemia—Betaxolol—glaucoma	0.00181	0.0029	CcSEcCtD
Pralatrexate—Pruritus—Brimonidine—glaucoma	0.0018	0.00289	CcSEcCtD
Pralatrexate—Thrombocytopenia—Clonidine—glaucoma	0.00179	0.00288	CcSEcCtD
Pralatrexate—Tachycardia—Clonidine—glaucoma	0.00179	0.00287	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—CTSA—glaucoma	0.00178	0.00526	CbGpPWpGaD
Pralatrexate—Nausea—Apraclonidine—glaucoma	0.00176	0.00283	CcSEcCtD
Pralatrexate—Anorexia—Clonidine—glaucoma	0.00175	0.00281	CcSEcCtD
Pralatrexate—Asthenia—Dorzolamide—glaucoma	0.00174	0.0028	CcSEcCtD
Pralatrexate—Asthenia—Travoprost—glaucoma	0.00173	0.00279	CcSEcCtD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00173	0.00513	CbGpPWpGaD
Pralatrexate—Pruritus—Dorzolamide—glaucoma	0.00172	0.00276	CcSEcCtD
Pralatrexate—Asthenia—Brinzolamide—glaucoma	0.00171	0.00275	CcSEcCtD
Pralatrexate—Pruritus—Travoprost—glaucoma	0.00171	0.00275	CcSEcCtD
Pralatrexate—Cough—Betaxolol—glaucoma	0.0017	0.00274	CcSEcCtD
Pralatrexate—Nausea—Bimatoprost—glaucoma	0.0017	0.00274	CcSEcCtD
Pralatrexate—DHFR—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.0017	0.00502	CbGpPWpGaD
Pralatrexate—Pruritus—Brinzolamide—glaucoma	0.00169	0.00271	CcSEcCtD
Pralatrexate—Vomiting—Acetazolamide—glaucoma	0.00168	0.00271	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—CA2—glaucoma	0.00168	0.00497	CbGpPWpGaD
Pralatrexate—Diarrhoea—Dorzolamide—glaucoma	0.00166	0.00267	CcSEcCtD
Pralatrexate—Diarrhoea—Travoprost—glaucoma	0.00165	0.00266	CcSEcCtD
Pralatrexate—Asthenia—Pilocarpine—glaucoma	0.00165	0.00264	CcSEcCtD
Pralatrexate—Dyspnoea—Clonidine—glaucoma	0.00163	0.00262	CcSEcCtD
Pralatrexate—Diarrhoea—Brinzolamide—glaucoma	0.00163	0.00262	CcSEcCtD
Pralatrexate—Pruritus—Pilocarpine—glaucoma	0.00162	0.00261	CcSEcCtD
Pralatrexate—Rash—Brimonidine—glaucoma	0.0016	0.00257	CcSEcCtD
Pralatrexate—Dermatitis—Brimonidine—glaucoma	0.0016	0.00257	CcSEcCtD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00159	0.00472	CbGpPWpGaD
Pralatrexate—Oedema—Betaxolol—glaucoma	0.00159	0.00256	CcSEcCtD
Pralatrexate—Decreased appetite—Clonidine—glaucoma	0.00159	0.00256	CcSEcCtD
Pralatrexate—Fatigue—Clonidine—glaucoma	0.00158	0.00254	CcSEcCtD
Pralatrexate—Nausea—Acetazolamide—glaucoma	0.00157	0.00253	CcSEcCtD
Pralatrexate—Diarrhoea—Pilocarpine—glaucoma	0.00157	0.00252	CcSEcCtD
Pralatrexate—Constipation—Clonidine—glaucoma	0.00157	0.00252	CcSEcCtD
Pralatrexate—Thrombocytopenia—Betaxolol—glaucoma	0.00156	0.00251	CcSEcCtD
Pralatrexate—FPGS—Metabolism—CA1—glaucoma	0.00156	0.00462	CbGpPWpGaD
Pralatrexate—Tachycardia—Betaxolol—glaucoma	0.00156	0.0025	CcSEcCtD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00155	0.00459	CbGpPWpGaD
Pralatrexate—Vomiting—Dorzolamide—glaucoma	0.00154	0.00248	CcSEcCtD
Pralatrexate—Rash—Dorzolamide—glaucoma	0.00153	0.00246	CcSEcCtD
Pralatrexate—Dermatitis—Dorzolamide—glaucoma	0.00153	0.00246	CcSEcCtD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—glaucoma	0.00152	0.00451	CbGpPWpGaD
Pralatrexate—Rash—Travoprost—glaucoma	0.00152	0.00245	CcSEcCtD
Pralatrexate—Dermatitis—Travoprost—glaucoma	0.00152	0.00245	CcSEcCtD
Pralatrexate—Anorexia—Betaxolol—glaucoma	0.00152	0.00244	CcSEcCtD
Pralatrexate—Vomiting—Brinzolamide—glaucoma	0.00152	0.00244	CcSEcCtD
Pralatrexate—DHFR—Cell Cycle—FGFR1OP—glaucoma	0.00152	0.00449	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CTSA—glaucoma	0.00151	0.00447	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00151	0.00447	CbGpPWpGaD
Pralatrexate—Nausea—Brimonidine—glaucoma	0.00151	0.00243	CcSEcCtD
Pralatrexate—Rash—Brinzolamide—glaucoma	0.0015	0.00242	CcSEcCtD
Pralatrexate—Dermatitis—Brinzolamide—glaucoma	0.0015	0.00242	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Clonidine—glaucoma	0.0015	0.00241	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00149	0.00442	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00148	0.00438	CbGpPWpGaD
Pralatrexate—Vomiting—Pilocarpine—glaucoma	0.00146	0.00234	CcSEcCtD
Pralatrexate—DHFR—E2F transcription factor network—CDKN2A—glaucoma	0.00145	0.0043	CbGpPWpGaD
Pralatrexate—Body temperature increased—Clonidine—glaucoma	0.00145	0.00233	CcSEcCtD
Pralatrexate—Abdominal pain—Clonidine—glaucoma	0.00145	0.00233	CcSEcCtD
Pralatrexate—Rash—Pilocarpine—glaucoma	0.00145	0.00232	CcSEcCtD
Pralatrexate—Dermatitis—Pilocarpine—glaucoma	0.00144	0.00232	CcSEcCtD
Pralatrexate—Nausea—Dorzolamide—glaucoma	0.00144	0.00232	CcSEcCtD
Pralatrexate—Nausea—Travoprost—glaucoma	0.00144	0.00231	CcSEcCtD
Pralatrexate—FPGS—Metabolism—CA2—glaucoma	0.00143	0.00422	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RAB8A—glaucoma	0.00143	0.00422	CbGpPWpGaD
Pralatrexate—Dyspnoea—Betaxolol—glaucoma	0.00142	0.00228	CcSEcCtD
Pralatrexate—Nausea—Brinzolamide—glaucoma	0.00142	0.00228	CcSEcCtD
Pralatrexate—Cough—Timolol—glaucoma	0.00139	0.00224	CcSEcCtD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00139	0.00412	CbGpPWpGaD
Pralatrexate—Decreased appetite—Betaxolol—glaucoma	0.00139	0.00223	CcSEcCtD
Pralatrexate—DHFR—Cell Cycle, Mitotic—OPTN—glaucoma	0.00138	0.00409	CbGpPWpGaD
Pralatrexate—Fatigue—Betaxolol—glaucoma	0.00137	0.00221	CcSEcCtD
Pralatrexate—SLC19A1—Disease—HDAC9—glaucoma	0.00137	0.00405	CbGpPWpGaD
Pralatrexate—Constipation—Betaxolol—glaucoma	0.00136	0.00219	CcSEcCtD
Pralatrexate—Nausea—Pilocarpine—glaucoma	0.00136	0.00219	CcSEcCtD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00135	0.00401	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NARFL—glaucoma	0.00133	0.00395	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA5A—glaucoma	0.00133	0.00395	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.00133	0.00394	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.00132	0.00392	CbGpPWpGaD
Pralatrexate—Asthenia—Clonidine—glaucoma	0.00131	0.00211	CcSEcCtD
Pralatrexate—Oedema—Timolol—glaucoma	0.0013	0.00209	CcSEcCtD
Pralatrexate—Pruritus—Clonidine—glaucoma	0.0013	0.00208	CcSEcCtD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1B—glaucoma	0.00128	0.00381	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.00127	0.00375	CbGpPWpGaD
Pralatrexate—Body temperature increased—Betaxolol—glaucoma	0.00126	0.00203	CcSEcCtD
Pralatrexate—Diarrhoea—Clonidine—glaucoma	0.00125	0.00201	CcSEcCtD
Pralatrexate—TYMS—Cell Cycle—RAB8A—glaucoma	0.00124	0.00368	CbGpPWpGaD
Pralatrexate—Anorexia—Timolol—glaucoma	0.00124	0.002	CcSEcCtD
Pralatrexate—DHFR—Cell Cycle—OPTN—glaucoma	0.00124	0.00366	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LRP12—glaucoma	0.00121	0.00357	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.00121	0.00357	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—TXN—glaucoma	0.00118	0.0035	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	0.00118	0.00349	CbGpPWpGaD
Pralatrexate—Vomiting—Clonidine—glaucoma	0.00116	0.00187	CcSEcCtD
Pralatrexate—TYMS—Metabolism—NARFL—glaucoma	0.00116	0.00345	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA5A—glaucoma	0.00116	0.00345	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HDAC9—glaucoma	0.00116	0.00344	CbGpPWpGaD
Pralatrexate—Dyspnoea—Timolol—glaucoma	0.00116	0.00187	CcSEcCtD
Pralatrexate—Rash—Clonidine—glaucoma	0.00115	0.00186	CcSEcCtD
Pralatrexate—Dermatitis—Clonidine—glaucoma	0.00115	0.00185	CcSEcCtD
Pralatrexate—Asthenia—Betaxolol—glaucoma	0.00114	0.00184	CcSEcCtD
Pralatrexate—Decreased appetite—Timolol—glaucoma	0.00113	0.00182	CcSEcCtD
Pralatrexate—Pruritus—Betaxolol—glaucoma	0.00113	0.00181	CcSEcCtD
Pralatrexate—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.00112	0.00333	CbGpPWpGaD
Pralatrexate—Fatigue—Timolol—glaucoma	0.00112	0.0018	CcSEcCtD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.00112	0.00332	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00112	0.00331	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00111	0.0033	CbGpPWpGaD
Pralatrexate—Diarrhoea—Betaxolol—glaucoma	0.00109	0.00175	CcSEcCtD
Pralatrexate—Nausea—Clonidine—glaucoma	0.00109	0.00175	CcSEcCtD
Pralatrexate—TYMS—Cell Cycle—OPTN—glaucoma	0.00108	0.00319	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.00107	0.00316	CbGpPWpGaD
Pralatrexate—Gastrointestinal pain—Timolol—glaucoma	0.00106	0.00171	CcSEcCtD
Pralatrexate—Body temperature increased—Timolol—glaucoma	0.00103	0.00165	CcSEcCtD
Pralatrexate—Abdominal pain—Timolol—glaucoma	0.00103	0.00165	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00103	0.00304	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.00102	0.00302	CbGpPWpGaD
Pralatrexate—Vomiting—Betaxolol—glaucoma	0.00101	0.00163	CcSEcCtD
Pralatrexate—Rash—Betaxolol—glaucoma	0.00101	0.00162	CcSEcCtD
Pralatrexate—FPGS—Metabolism—TXN—glaucoma	0.001	0.00298	CbGpPWpGaD
Pralatrexate—Dermatitis—Betaxolol—glaucoma	0.001	0.00161	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—TNF—glaucoma	0.000993	0.00294	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000974	0.00289	CbGpPWpGaD
Pralatrexate—Nausea—Betaxolol—glaucoma	0.000947	0.00152	CcSEcCtD
Pralatrexate—Asthenia—Timolol—glaucoma	0.000934	0.0015	CcSEcCtD
Pralatrexate—DHFR—G1/S Transition—CDKN1B—glaucoma	0.000932	0.00276	CbGpPWpGaD
Pralatrexate—Pruritus—Timolol—glaucoma	0.000921	0.00148	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—GSTT1—glaucoma	0.000916	0.00271	CbGpPWpGaD
Pralatrexate—Diarrhoea—Timolol—glaucoma	0.000891	0.00143	CcSEcCtD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000887	0.00263	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—glaucoma	0.000875	0.00259	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000872	0.00258	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000837	0.00248	CbGpPWpGaD
Pralatrexate—Vomiting—Timolol—glaucoma	0.000828	0.00133	CcSEcCtD
Pralatrexate—Rash—Timolol—glaucoma	0.000821	0.00132	CcSEcCtD
Pralatrexate—Dermatitis—Timolol—glaucoma	0.00082	0.00132	CcSEcCtD
Pralatrexate—TYMS—G1/S Transition—CDKN1B—glaucoma	0.000813	0.00241	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000786	0.00233	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTT1—glaucoma	0.000779	0.00231	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR1OP—glaucoma	0.000778	0.0023	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HEYL—glaucoma	0.000778	0.0023	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000774	0.00229	CbGpPWpGaD
Pralatrexate—Nausea—Timolol—glaucoma	0.000774	0.00124	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000746	0.00221	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN2B—glaucoma	0.000735	0.00218	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ABCA1—glaucoma	0.00073	0.00216	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CYP1B1—glaucoma	0.00073	0.00216	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000702	0.00208	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000686	0.00203	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA1—glaucoma	0.000651	0.00193	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND2—glaucoma	0.000635	0.00188	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CTSA—glaucoma	0.000631	0.00187	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN2B—glaucoma	0.000625	0.00185	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ABCA1—glaucoma	0.000621	0.00184	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CYP1B1—glaucoma	0.000621	0.00184	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTHFR—glaucoma	0.000616	0.00182	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000612	0.00181	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CA2—glaucoma	0.000596	0.00176	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GSTM1—glaucoma	0.000584	0.00173	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—APOE—glaucoma	0.000573	0.0017	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000569	0.00169	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA1—glaucoma	0.000568	0.00168	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CAV1—glaucoma	0.000568	0.00168	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND2—glaucoma	0.000567	0.00168	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.000554	0.00164	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CTSA—glaucoma	0.00055	0.00163	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000548	0.00162	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—BAD—glaucoma	0.000534	0.00158	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTHFR—glaucoma	0.000524	0.00155	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA2—glaucoma	0.00052	0.00154	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000519	0.00154	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—MTHFR—glaucoma	0.000516	0.00153	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2B—glaucoma	0.000509	0.00151	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000496	0.00147	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTM1—glaucoma	0.000496	0.00147	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND2—glaucoma	0.000495	0.00147	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOE—glaucoma	0.000488	0.00144	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC9—glaucoma	0.000485	0.00144	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CAV1—glaucoma	0.000483	0.00143	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOE—glaucoma	0.00048	0.00142	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CAV1—glaucoma	0.000476	0.00141	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BAD—glaucoma	0.000454	0.00135	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000444	0.00131	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MTHFR—glaucoma	0.000439	0.0013	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000432	0.00128	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS3—glaucoma	0.00043	0.00127	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TXN—glaucoma	0.00042	0.00124	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOE—glaucoma	0.000408	0.00121	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CAV1—glaucoma	0.000405	0.0012	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—glaucoma	0.000393	0.00116	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—glaucoma	0.000372	0.0011	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.00037	0.0011	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TXN—glaucoma	0.000366	0.00108	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS3—glaucoma	0.000365	0.00108	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—glaucoma	0.00036	0.00107	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—glaucoma	0.000334	0.000989	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—glaucoma	0.000329	0.000975	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000326	0.000967	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—glaucoma	0.000325	0.000964	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000325	0.000964	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—glaucoma	0.000316	0.000937	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—glaucoma	0.000313	0.000928	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—glaucoma	0.000306	0.000906	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—glaucoma	0.000291	0.000862	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000288	0.000853	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—glaucoma	0.000284	0.000841	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000284	0.000841	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—glaucoma	0.00028	0.000829	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—glaucoma	0.000261	0.000773	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCA1—glaucoma	0.000259	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1B1—glaucoma	0.000259	0.000768	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—glaucoma	0.000258	0.000763	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—glaucoma	0.000254	0.000752	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000251	0.000745	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCA1—glaucoma	0.000226	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1B1—glaucoma	0.000226	0.00067	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—glaucoma	0.000225	0.000666	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—glaucoma	0.000219	0.000648	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—glaucoma	0.000207	0.000614	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOE—glaucoma	0.000204	0.000603	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CAV1—glaucoma	0.000202	0.000598	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BAD—glaucoma	0.00019	0.000562	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—glaucoma	0.000183	0.000543	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—glaucoma	0.000181	0.000536	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOE—glaucoma	0.000171	0.000505	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAV1—glaucoma	0.000169	0.000501	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—glaucoma	0.000162	0.00048	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—glaucoma	0.00016	0.000473	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—glaucoma	0.000153	0.000452	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOE—glaucoma	0.000149	0.000441	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAV1—glaucoma	0.000147	0.000437	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—glaucoma	0.000141	0.000418	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—glaucoma	0.00014	0.000413	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—glaucoma	0.000132	0.000391	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—glaucoma	0.000128	0.000378	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—glaucoma	0.000117	0.000346	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—glaucoma	0.000111	0.00033	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—glaucoma	0.000102	0.000302	CbGpPWpGaD
